 Mia Smith
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 14 | 2023 | 770 | 3.620 |
Why?
| | Clonal Anergy | 6 | 2018 | 54 | 1.620 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2023 | 3360 | 1.180 |
Why?
| | Autoantibodies | 6 | 2023 | 1335 | 1.030 |
Why?
| | Autoimmunity | 5 | 2023 | 831 | 1.030 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 330 | 1.020 |
Why?
| | Prediabetic State | 2 | 2018 | 234 | 0.920 |
Why?
| | Autoimmune Diseases | 2 | 2023 | 398 | 0.810 |
Why?
| | Islets of Langerhans | 3 | 2020 | 739 | 0.660 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2017 | 15 | 0.640 |
Why?
| | Graves Disease | 1 | 2017 | 32 | 0.620 |
Why?
| | T-Lymphocytes | 4 | 2023 | 1774 | 0.620 |
Why?
| | Thyroid Gland | 1 | 2017 | 84 | 0.610 |
Why?
| | Antibody-Producing Cells | 1 | 2017 | 29 | 0.600 |
Why?
| | Magnetic Fields | 1 | 2017 | 23 | 0.600 |
Why?
| | Cell Separation | 1 | 2017 | 296 | 0.550 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 289 | 0.480 |
Why?
| | Nanoparticles | 1 | 2017 | 325 | 0.450 |
Why?
| | Insulin | 4 | 2023 | 2162 | 0.300 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 827 | 0.250 |
Why?
| | Flow Cytometry | 2 | 2018 | 1085 | 0.240 |
Why?
| | Immune Tolerance | 2 | 2017 | 334 | 0.230 |
Why?
| | CD79 Antigens | 2 | 2014 | 14 | 0.230 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 14 | 0.210 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 409 | 0.190 |
Why?
| | Humans | 13 | 2023 | 118974 | 0.190 |
Why?
| | Mice, Inbred NOD | 2 | 2018 | 574 | 0.170 |
Why?
| | Age of Onset | 1 | 2020 | 467 | 0.170 |
Why?
| | Lymphocyte Activation | 3 | 2017 | 1067 | 0.160 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2018 | 11 | 0.160 |
Why?
| | B7-2 Antigen | 1 | 2017 | 25 | 0.160 |
Why?
| | Ikaros Transcription Factor | 1 | 2018 | 17 | 0.160 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 30 | 0.160 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.150 |
Why?
| | Receptors, Antigen, B-Cell | 2 | 2016 | 101 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1171 | 0.150 |
Why?
| | HLA-DQ Antigens | 1 | 2018 | 176 | 0.150 |
Why?
| | HLA-DR Antigens | 1 | 2018 | 224 | 0.150 |
Why?
| | Cell Count | 1 | 2017 | 315 | 0.140 |
Why?
| | Epitopes | 1 | 2017 | 443 | 0.130 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 4908 | 0.130 |
Why?
| | Pandemics | 1 | 2023 | 1355 | 0.130 |
Why?
| | Monocytes | 1 | 2018 | 513 | 0.130 |
Why?
| | Antibodies, Viral | 2 | 2022 | 542 | 0.130 |
Why?
| | Immunoglobulins | 1 | 2014 | 154 | 0.120 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 82 | 0.120 |
Why?
| | Cloning, Molecular | 1 | 2014 | 546 | 0.120 |
Why?
| | Animals | 7 | 2020 | 33381 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4552 | 0.110 |
Why?
| | Gammaherpesvirinae | 1 | 2012 | 39 | 0.110 |
Why?
| | Antigens, CD | 1 | 2014 | 460 | 0.110 |
Why?
| | B-Lymphocyte Subsets | 1 | 2012 | 66 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 4077 | 0.100 |
Why?
| | Autoantigens | 1 | 2014 | 397 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 702 | 0.100 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2011 | 57 | 0.100 |
Why?
| | Mice | 6 | 2018 | 15520 | 0.100 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 142 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 356 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2016 | 984 | 0.090 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 228 | 0.090 |
Why?
| | Time Factors | 1 | 2020 | 6412 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2275 | 0.080 |
Why?
| | Phenotype | 1 | 2017 | 3003 | 0.080 |
Why?
| | Inflammation | 3 | 2022 | 2566 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2445 | 0.060 |
Why?
| | Female | 4 | 2018 | 61565 | 0.060 |
Why?
| | Lymphocyte Depletion | 2 | 2014 | 119 | 0.060 |
Why?
| | Male | 3 | 2018 | 57801 | 0.060 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.060 |
Why?
| | Immunoglobulin D | 1 | 2022 | 28 | 0.060 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2022 | 688 | 0.040 |
Why?
| | Signal Transduction | 1 | 2011 | 4709 | 0.040 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2016 | 72 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2012 | 2025 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2014 | 2680 | 0.040 |
Why?
| | Clone Cells | 1 | 2016 | 248 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2016 | 334 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 310 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 28 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 509 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2014 | 136 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 174 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 896 | 0.030 |
Why?
| | Rituximab | 1 | 2014 | 155 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 75 | 0.030 |
Why?
| | Inositol Polyphosphate 5-Phosphatases | 1 | 2011 | 4 | 0.030 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2011 | 13 | 0.030 |
Why?
| | Gene Targeting | 1 | 2011 | 80 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2012 | 278 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 200 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2011 | 90 | 0.020 |
Why?
| | Tyrosine | 1 | 2011 | 233 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 940 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2011 | 308 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3171 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1489 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 371 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2014 | 1284 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1633 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2851 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1346 | 0.020 |
Why?
|
|
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|